The Mesothelioma Center News – Page 9

• 

  Research & Clinical Trials

  Mesothelioma Clinical Trial Involves Immunotherapy Before Surgery

  Three of the country’s leading cancer centers have opened a collaborative clinical trial that potentially could change surgical treatment of mesothelioma. Researchers will…

  

  Tim Povtak

  February 24, 2020
• 

  Treatment & Doctors

  Mesothelioma Detection May Come Earlier with Liquid Biopsy

  Cellular Analytics, a biotechnology company in Ontario, Canada, has unveiled a novel liquid biopsy test for mesothelioma that could lead to more effective…

  

  Tim Povtak

  February 18, 2020
• 

  Research & Clinical Trials

  Mesothelioma Gene Therapy Trial Shows ‘Real Potential’

  Gene therapy is moving closer to becoming part of standard-of-care treatment for pleural mesothelioma, according to the latest multicenter clinical trial. The phase…

  

  Tim Povtak

  February 17, 2020
• 

  Treatment & Doctors

  Alternative to Alimta Coming for Mesothelioma Patients

  The U.S. Food and Drug Administration has granted final approval of Pemfexy, a new brand of the chemotherapy drug pemetrexed, to combat malignant…

  

  Tim Povtak

  February 12, 2020
• 

  Asbestos Exposure & Bans

  FDA Moves Closer to Standardized Testing for Asbestos in Talc

  The U.S. Food and Drug Administration moved closer on Tuesday to formulating standardized testing of talc-based products for the presence of toxic asbestos…

  

  Tim Povtak

  February 5, 2020
• 

  Research & Clinical Trials

  Duke Completes Largest Study of Mesothelioma in Women

  Women diagnosed with peritoneal mesothelioma were 10 years younger on average than those with pleural mesothelioma in a recent case study at the Duke…

  

  Tim Povtak

  February 5, 2020
• 

  Asbestos Exposure & Bans

  Mesothelioma Deaths Peak 30 Years After Asbestos Ban

  Almost 30 years after Italy passed sweeping legislation that banned the mining, use and commercialization of asbestos, the country is facing the peak…

  

  Tim Povtak

  January 30, 2020
• 

  Research & Clinical Trials

  ONCOS-102 Shows Promise in Combination Mesothelioma Treatment

  ONCOS-102, a promising immunotherapy vaccine, is moving closer to becoming a part of future first-line treatment for mesothelioma. Early clinical trial results…

  

  Tim Povtak

  January 27, 2020
• 

  Asbestos Exposure & Bans

  FDA Panel Recommends Standardized Talc Testing for Asbestos

  A team of experts from eight different federal agencies has presented the U.S. Food and Drug Administration with preliminary recommendations to standardize the testing…

  

  Tim Povtak

  January 21, 2020
• 

  Research & Clinical Trials

  Study Uncovers Drug Combination for Sarcomatoid Mesothelioma

  Researchers in Spain have discovered a drug combination showing potential in treating the most difficult-to-treat type of malignant mesothelioma. Selumetinib and AZD8186, already…

  

  Tim Povtak

  January 16, 2020